Related Experiment Video
Updated: Nov 4, 2025

Bacterial Artificial Chromosomes: A Functional Genomics Tool for the Study of Positive-strand RNA Viruses
Published on: December 29, 2015
Management of Japanese Encephalitis: A Current Update
Abimbola O Ajibowo1, Juan Fernando Ortiz2,3, Ammar Alli4,5
1Internal Medicine, Fort Worth Renal Group, Dallas, USA.
Minocycline shows promise for treating Japanese encephalitis (JE), a serious viral infection. While other drugs like IVIG had limited success, minocycline demonstrated statistically significant results in one study, offering hope for JE patients.
Area of Science:
- Neurology
- Infectious Diseases
- Pharmacology
Background:
- Japanese encephalitis (JE) is a severe global infection with high mortality and morbidity.
- Current treatment options and guidelines for JE are limited, necessitating further research.
Purpose of the Study:
- To review and analyze recent studies on Japanese encephalitis treatments.
- To provide healthcare providers with evidence-based information for clinical decision-making.
Main Methods:
- Advanced PubMed search for studies on JE treatments using specific drugs (minocycline, interferon, ribavirin, immunoglobulin, dexamethasone, acyclovir).
- Inclusion criteria: full papers in English, human studies.
- Comparative analysis of recent research findings.
Main Results:
- Minocycline demonstrated promising results, with one study showing statistical significance.
- A second minocycline study indicated positive trends in specific patient groups (children >12 years, early survivors).
- Intravenous immunoglobulin (IVIG) did not improve outcomes but increased neutralizing antibodies; further high-dose studies are suggested. Other drugs showed no significant benefits.
Conclusions:
- Minocycline is a potential therapeutic agent for Japanese encephalitis, warranting further investigation.
- Current evidence does not support the use of interferon, ribavirin, dexamethasone, or acyclovir for JE treatment.
- Intravenous immunoglobulin may play a role in antibody response, but clinical efficacy requires more research.
Related Concept Videos
Endocarditis III: Medical Management
Myocarditis III: Medical Management
Myocarditis IV: Nursing Management
Rheumatic Heart Disease III: Medical Management
Methods of reducing fever
Pharmacological Methods of Reducing Fever:
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

